Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Rush with Ruch Season 1 Triumphantly Concludes with Star-Studded Success Party hosted by Ruchita Sharma Entertainment
  • Grand Launch of “Dulhan Diaries” by OOPSROOPS Business
  • Design That Thinks, Feels, and Leads: Inside the M.A. Communication Design Program at SDMCA Education
  • Softone launches Re-Hear, India’s first hearing aid with advanced features Business
  • Minerva Ventures Fund bought total 2 Percent stake in KBC Global Ltd Business
  • Business Mint Recognized Mohsin Khan, as Best Emerging CEO of the Year 2022 in Celebrity Management Category Business
  • ClearZorb Announces Raj Shamani as Brand Ambassador Business
  • The Real-Estate Innovations – Sharhabeel Parambil, (Managing director, Continental Towers and Billets Pvt. Ltd.) Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Empower India Limited Announces Signing of Term Sheet for Strategic Cross-Border Acquisition of UAE-Based MABIL Business
  • Syndicate Investments brings the best investment options to beat the economic crisis Business
  • Rikhav Securities Limited Reports EBITDA of Rs 32.53 Cr & PAT of Rs 18.96 Cr in FY26 Business
  • PVSSR Anjaneyulu: A Visionary Leader in Healthcare and Marketing Business
  • Tilak Banerjee steps forward to organise the unorganised Seafood and Meat Market through Pescadoo Business
  • Doctor-Founded Glo Mama Revolutionises Pregnancy Wellness with Holistic Approach Business

Recent Posts

  • Masumi Mewawalla Brings Her Signature Couture Aesthetic to Coffee with Couples
  • Dimension NXG Launches OJAS Forward Deployed Engineering to Take Hospital AI From Pilot to Patient, Six Months Ahead of India’s Data Protection Deadline
  • Sarvajanik University Extends Diwali and New Year Greetings
  • Why American Pistachios are Taking Over Modern Luxury Diwali Gifting Hampers
  • The Festive Mithai Makeover: Chef Hina Gujral Shares 2 Traditional Indian Sweets That Taste Better with U.S. Cranberries

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • All You Need to Know about Arvind Tiwari’s Creative and Integrated Campaigns Business
  • Sheth Realty Marks the Commencement of its New Mulund Development with Bhoomi Pujan Business
  • New Delhi’s Cultural Gem: TRIS Exhibition Draws Luminaries and Enthusiasts Alike National
  • Union Minister Smriti Irani Inaugurates the “Orphan Research and Development Academy Center” by Tarpan Foundation National
  • Explore NPST solution at the Global FinTech Fest 2022 Business
  • Paperex 2023, World’s Largest Paper Show, all set to showcase top brands and Latest Technology Business
  • Scaling New Heights: Saturo Technologies Expands to a Bigger Office in Pune’s Tech Hub Business
  • Dr. Ravishankar Polisetty Unveils Strategy to Position India as Global Healthcare Leader Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme